Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs allopurinol in primary gout with hyperuricemia (phase II, China)
CTR20130172Phase 2Completed
- Sponsor
- Chongqing Shenghuaxi Pharmaceutical
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in idiopathic gout, hyperuricemia, sponsored by Chongqing Shenghuaxi Pharmaceutical. Started Sep 2015; status: completed.
02
Drugs
febuxostat
03
Conditions
idiopathic gouthyperuricemia
Beyond the preview
Go deeper on CTR20130172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130172.